Platform
Applications
Partnerships
Team
Media
Contact Us
Careers
Profluent
Contact Us
Careers
Menu
Close
STAT News
Profluent
|
Published
Apr 28, 2026
Eli Lilly enlists AI startup for next-generation gene editors
XX
min read
TL;DR
Sign up for updates on our journey
Email Address
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
STAT News
|
Published
Apr 28, 2026
Share on Social
Share on Twitter
Share on LinkedIn
Share on Facebook
More media
July 9, 2026
ARPA-H awards to advance personalized curative medicines for rare genetic diseases
Announcement
July 9, 2026
ARPA-H awards to advance personalized curative medicines for rare genetic diseases
Announcement
July 9, 2026
GEMMABio Awarded ARPA-H Funding to Pursue Innovative Base-editing Strategy for Rare Liver Diseases
Announcement
July 9, 2026
GEMMABio Awarded ARPA-H Funding to Pursue Innovative Base-editing Strategy for Rare Liver Diseases
Announcement
April 28, 2026
Lilly, Profluent Ink Deal on AI Drugs Worth Up to $2.25 Billion
Press
April 28, 2026
Lilly, Profluent Ink Deal on AI Drugs Worth Up to $2.25 Billion
Press
All Media
